Skip to main content
Manufacturers, veterinarians see promise in animal health biotech

The falling costs associated with genetic testing and development of biotech therapies means those treatments are finally becoming accessible for pets, and the itch-relieving treatment Cytopoint has shown how successful biotech treatments for animals can be, said veterinarian Cheryl London of the Cummings School of Veterinary Medicine at Tufts University. Dr. London said estimates indicate there are five to 10 companies working on biotech treatments, including an immunotherapy that is now being tested for treatment of canine cancer in a clinical trial at Tufts.

Full Story: